{"id":"W2883714441","doi":"10.1371/journal.pone.0199297","title":"Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)","year":2018,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Regimen; Epirubicin; Breast cancer; Docetaxel; Clinical trial; Clinical endpoint; Triple-negative breast cancer; Chemotherapy regimen; Internal medicine; Randomized controlled trial; Oncology; Cyclophosphamide; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01171228,0.001628775,0.002216605,0.0004600006,0.0005427198,0.001261433,0.001195457,0.003018021,0.01084703],"category_scores_gemma":[0.0145323,0.0007260512,0.001980986,0.0004757495,0.002115438,0.001640457,0.001173909,0.003694216,0.001523416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001158086,"about_ca_system_score_gemma":0.002828996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000715274,"about_ca_topic_score_gemma":0.001012992,"domain_scores_codex":[0.9917744,0.006587003,0.0003919419,0.000509345,0.0003760301,0.0003613213],"domain_scores_gemma":[0.9912568,0.003791056,0.002456979,0.000682736,0.0004812339,0.001331318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9824315,0.005618369,0.0005017256,0.0005689402,0.0003558453,0.00003446807,0.00009299823,0.0003369687,0.0006972579,0.0002812967,0.0005536657,0.008526952],"study_design_scores_gemma":[0.9054065,0.09199184,0.0008064182,0.00005875005,0.0001916826,0.00002330306,0.00002344331,0.0002453035,0.0001856753,0.000287364,0.0007688309,0.0000109662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8965376,0.003733473,0.003685039,0.003067382,0.001843885,0.0835133,0.001828495,0.0002591537,0.005531718],"genre_scores_gemma":[0.8814855,0.001586709,0.01201731,0.002844662,0.001006853,0.09369677,0.001814633,0.00003818049,0.005509378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01171228,"threshold_uncertainty_score":0.06194121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.440848941581341,"score_gpt":0.5175759428666381,"score_spread":0.07672700128529714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}